Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for infants born in settings with high HIV burdens. - Alba C; Malhotra S; Horsfall S; Barnhart ME; Bekker A; Chapman K; Cunningham CK; Fast PE; Fouda GG; Freedberg KA; Goga A; Ghazaryan LR; et al. (PloS one, 2025)